|Day's Range||58.88 - 60.88|
|52 Week Range||28.76 - 61.95|
|PE Ratio (TTM)||15.50|
|Dividend & Yield||1.18 (2.00%)|
|1y Target Est||N/A|
Mallinckrodt Pharmaceuticals, which produces specialty pharmaceutical products such as generic drugs and imaging agents, surged to a ten-day high on May 26.
As of May 25, 16 of the 27 (59%) analysts covering BBY had a “hold” recommendation on the stock. Eight analysts had a “buy” recommendation.
Best Buy's valuation multiple rose 16.5% on May 25 in reaction to its fiscal 1Q18 results and a better outlook.